Senti Biosciences, Inc. filed its Annual on Feb 14, 2022 for the period ending Dec 31, 2020. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2787 USD | -0.78% | -3.90% | -57.77% |
Mar. 21 | Senti Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | Earnings Flash (SNTI) SENTI BIOSCIENCES Reports 2023 Revenue $2.6M | MT |
1st Jan change | Capi. | |
---|---|---|
-57.77% | 12.75M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.82% | 22.02B | |
-17.84% | 20.9B | |
-9.33% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- SNTI Stock
- News Senti Biosciences, Inc.
- Senti Biosciences, Inc. Auditor Raises 'Going Concern' Doubt